CVR Energy vs Delek US
CVI and DK side by side, both in petroleum refining. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVI and DK compare
CVR Energy and Delek US are about the same size, with market caps of $4.1B and $4.1B.
On earnings, Delek US is cheaper: it trades at 3.6× trailing earnings, against 58.9× for CVR Energy.
Delek US grew revenue faster over the last twelve months (27.1% versus 17.9% for CVR Energy).
Delek US keeps more of each dollar of sales as profit, with a net margin of 8.7% compared with 0.81% at CVR Energy.
Both pay dividends: CVR Energy yields 0.49% and Delek US 1.1%.
Delek US scores higher on the StockData Score (14 against 5 for CVR Energy), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVI | DK |
|---|---|---|
| Size and price | ||
| Market cap | $4.1B | $4.1B |
| Share price | $40.61 | $67.16 |
| Change, 1 year | 10.1% | 61.8% |
| Change, 5 years | 154% | 334% |
| Beta (5Y) | 0.74 | 0.51 |
| Employees | 1,532 | 1,902 |
| StockData Score | ||
| Total score | 5 | 14 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 2 | 2 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 58.9× | 3.6× (better) |
| P/S | 0.5× | 0.3× (better) |
| P/B | 7.8× | – |
| EV/EBITDA | 7.8× | 2.9× (better) |
| P/FCF | 11.6× | 3.4× (better) |
| FCF yield | 8.6% | 29.2% (better) |
| Fair value | $31.10 | $240.46 |
| Margin of safety | −30.6% | 72.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 17.9% | 27.1% (better) |
| Revenue growth, 5Y average | 12.8% (better) | 8.0% |
| Profitability | ||
| Gross margin | 6.1% | 15.0% (better) |
| Operating margin | 4.1% | 13.3% (better) |
| Net margin | 0.81% | 8.7% (better) |
| FCF margin | 4.1% | 8.9% (better) |
| Return on equity | 13.9% | – |
| Return on invested capital | 15.6% | – |
| Financial health | ||
| Debt / equity | 3.40 | – |
| Net debt / EBITDA | 1.52 | 0.92 (better) |
| Current ratio | 1.42 (better) | 1.33 |
| Altman Z-score | 2.91 (better) | 2.90 |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.49% | 1.1% (better) |
| Payout ratio | – | 5.3% |
| Years of dividend growth | – | 4 |
| Dividend growth, 5Y average | – | 1.9% |
| Shareholder yield | 0.49% | 1.1% (better) |
| Ownership | ||
| Held by institutions | 103% | 101% |
| Held by insiders | – | 2.4% |
| Insider net buying, 12 months | $16.4M (better) | −$46.5M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | – | 12.5% |
Go deeper
- CVI stock overview
- CVI income statement
- CVI valuation and score
- DK stock overview
- DK income statement
- DK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.